Potential Health Risks of Snus: A Popular Tobacco Alternative

Industry Insight by 2FIRSTS.ai
Jan.08.2024
Potential Health Risks of Snus: A Popular Tobacco Alternative
Snus, a popular tobacco alternative, is facing health concerns as experts warn of potential risks.

According to a recent report by LadBible, an alternative product called Snus (a tobacco-filled pouch) is gaining popularity, but experts are warning of potential health risks associated with this product. For those unfamiliar with this term, Snus is essentially a tobacco product that resembles small tea bags.

 

Snus, originating from Northern Europe, has been widely popular there and has actually become the most common type of tobacco product in Norway. It is also gaining increasing popularity among young people. However, in all European Union countries, as well as Australia and New Zealand, Snus is even illegal.

 

This small tobacco pouch is placed under a person's lip for approximately thirty minutes, often likened to a disposable tea bag. However, due to its nicotine content, Snus can be addictive.

 

Toxicology management consultant Libby Clarke has informed the media that the absorption of nicotine through oral products is slower compared to smoking cigarettes or e-cigarettes, suggesting that their potential for addiction may be lower.

 

However, a London dentist has warned on social media that using Snus by placing it on the gums may cause harm to the mouth, leading to gum disease and gingivitis, and possibly even pre-cancerous conditions. Currently, there is not a lot of data on the safety of Snus, but in theory, this product should be better than cigarettes, although it still poses health risks.

 

Pharmacist Ian Budd added that due to the presence of nicotine, Snus is considered an addictive substance, which is what initially leads to smoking addiction. Certain studies have indicated a potential correlation between Snus usage and higher rates of pancreatic cancer, heart failure, and diabetes, although research on this matter is still ongoing.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Singapore tightens vape enforcement, mandates rehab for etomidate users
Singapore tightens vape enforcement, mandates rehab for etomidate users
Singapore’s Ministry of Health (MOH) and Health Sciences Authority (HSA) reported that from Sep 1 to Oct 12, 1,339 people were caught for vape-related offences, including 102 found in possession of etomidate-laced vapes.
Oct.17 by 2FIRSTS.ai
NSW Police Seize About US$1.9 Million in Illegal Tobacco Products, Including 15,000 Vapes
NSW Police Seize About US$1.9 Million in Illegal Tobacco Products, Including 15,000 Vapes
During a recent routine traffic stop, New South Wales police discovered a large quantity of illegal tobacco and vapes hidden inside a rental truck, including approximately 942,000 cigarettes and more than 15,000 e-cigarettes, with an estimated value of nearly AUD 2 million. The 31-year-old driver was arrested at the scene and the case has now entered judicial proceedings.
Dec.01 by 2FIRSTS.ai
South Korean Parliament advances revision of tobacco law to include synthetic nicotine products, expected to generate $6.3 billion in tax revenue
South Korean Parliament advances revision of tobacco law to include synthetic nicotine products, expected to generate $6.3 billion in tax revenue
South Korean Parliament advances tobacco law revision, including synthetic nicotine products, anticipating $630 million tax revenue increase.
Oct.16 by 2FIRSTS.ai
Congress Calls on FDA to Allocate at Least $200 Million for ENDS Enforcement, Multi-Agency Task Force to Target Illegal e-Cigarette Imports. IKE Tech and Ispire Utilize Blockchain and Age Verification Technology to Support Regulation, Submit Chips as Part
Congress Calls on FDA to Allocate at Least $200 Million for ENDS Enforcement, Multi-Agency Task Force to Target Illegal e-Cigarette Imports. IKE Tech and Ispire Utilize Blockchain and Age Verification Technology to Support Regulation, Submit Chips as Part
Congress demands FDA allocate at least $200 million for ENDS enforcement; multi-agency task force to combat illegal e-cigarette imports.
Nov.18 by 2FIRSTS.ai
British American Tobacco’s Irish unit says VELO pouch sales hit 29m, net revenue climbs to €33.75m
British American Tobacco’s Irish unit says VELO pouch sales hit 29m, net revenue climbs to €33.75m
British American Tobacco’s Irish subsidiary PJ Carroll & Co Ltd reported that sales of its Velo nicotine pouches nearly quintupled in 2024 to 29 million units, driving an 11% year-on-year increase in net revenue to €33.75 million. However, amid a heavy tax burden and declining traditional cigarette volumes, the company’s pre-tax profit fell 8% to €5.69 million.
Dec.01 by 2FIRSTS.ai
Product | GEEK BAR and Canada’s STLTH Co-Launch 80,000-Puff Vape, Now Available Across Multiple Channels
Product | GEEK BAR and Canada’s STLTH Co-Launch 80,000-Puff Vape, Now Available Across Multiple Channels
Canada’s STLTH has teamed up with GEEK BAR to launch the disposable “STLTH X GEEK BAR 80K,” featuring 30 ml of e-liquid and up to 80,000 puffs. The device is now available across multiple retail channels in Canada, priced around C$44.99–48.99.
Oct.30 by 2FIRSTS.ai